321 related articles for article (PubMed ID: 35631477)
1. Nanobiotechnology with Therapeutically Relevant Macromolecules from Animal Venoms: Venoms, Toxins, and Antimicrobial Peptides.
Roque-Borda CA; Gualque MWL; da Fonseca FH; Pavan FR; Santos-Filho NA
Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631477
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles Functionalized with Venom-Derived Peptides and Toxins for Pharmaceutical Applications.
Dos Santos AP; de Araújo TG; Rádis-Baptista G
Curr Pharm Biotechnol; 2020; 21(2):97-109. PubMed ID: 31223083
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical nanotechnology: Antimicrobial peptides as potential new drugs against WHO list of critical, high, and medium priority bacteria.
Roque-Borda CA; Bento da Silva P; Rodrigues MC; Di Filippo LD; Duarte JL; Chorilli M; Vicente EF; Garrido SS; Rogério Pavan F
Eur J Med Chem; 2022 Nov; 241():114640. PubMed ID: 35970075
[TBL] [Abstract][Full Text] [Related]
4. Venom peptides in cancer therapy: An updated review on cellular and molecular aspects.
Mirzaei S; Fekri HS; Hashemi F; Hushmandi K; Mohammadinejad R; Ashrafizadeh M; Zarrabi A; Garg M
Pharmacol Res; 2021 Feb; 164():105327. PubMed ID: 33276098
[TBL] [Abstract][Full Text] [Related]
5. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
Grumezescu AM; Chifiriuc CM
Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
[TBL] [Abstract][Full Text] [Related]
6. Minor snake venom proteins: Structure, function and potential applications.
Boldrini-França J; Cologna CT; Pucca MB; Bordon KC; Amorim FG; Anjolette FA; Cordeiro FA; Wiezel GA; Cerni FA; Pinheiro-Junior EL; Shibao PY; Ferreira IG; de Oliveira IS; Cardoso IA; Arantes EC
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):824-838. PubMed ID: 28012742
[TBL] [Abstract][Full Text] [Related]
7. Small peptides, big world: biotechnological potential in neglected bioactive peptides from arthropod venoms.
Pimenta AM; De Lima ME
J Pept Sci; 2005 Nov; 11(11):670-6. PubMed ID: 16103988
[TBL] [Abstract][Full Text] [Related]
8. New insights on arthropod toxins that potentiate erectile function.
Nunes KP; Torres FS; Borges MH; Matavel A; Pimenta AM; De Lima ME
Toxicon; 2013 Jul; 69():152-9. PubMed ID: 23583324
[TBL] [Abstract][Full Text] [Related]
9. Animal Venom Peptides: Potential for New Antimicrobial Agents.
Primon-Barros M; José Macedo A
Curr Top Med Chem; 2017; 17(10):1119-1156. PubMed ID: 27697042
[TBL] [Abstract][Full Text] [Related]
10. Animal venom studies: Current benefits and future developments.
Utkin YN
World J Biol Chem; 2015 May; 6(2):28-33. PubMed ID: 26009701
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular-Active Venom Toxins: An Overview.
Rebello Horta CC; Chatzaki M; Rezende BA; Magalhães Bde F; Duarte CG; Felicori LF; Ribeiro Oliveira-Mendes BB; do Carmo AO; Chávez-Olórtegui C; Kalapothakis E
Curr Med Chem; 2016; 23(6):603-22. PubMed ID: 26812904
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential.
Biswas A; Gomes A; Sengupta J; Datta P; Singha S; Dasgupta AK; Gomes A
J Venom Res; 2012; 3():15-21. PubMed ID: 23236583
[TBL] [Abstract][Full Text] [Related]
13. Applications of Venom Proteins as Potential Anticancer Agents.
Ejaz S; Hashmi FB; Malik WN; Ashraf M; Nasim FU; Iqbal M
Protein Pept Lett; 2018; 25(7):688-701. PubMed ID: 29921199
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-peptide conjugates for bacterial detection and neutralization: Potential applications in diagnostics and therapy.
Gonçalves S; Martins IC; Santos NC
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1819. PubMed ID: 36416027
[TBL] [Abstract][Full Text] [Related]
15. [Ants: a chemical library of anticancer molecules].
Vétillard A; Bouzid W
Biol Aujourdhui; 2016; 210(2):119-25. PubMed ID: 27687602
[TBL] [Abstract][Full Text] [Related]
16. Effects of Animal Venoms and Toxins on Hallmarks of Cancer.
Chaisakul J; Hodgson WC; Kuruppu S; Prasongsook N
J Cancer; 2016; 7(11):1571-8. PubMed ID: 27471574
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Activity Developed by Scorpion Venoms and Its Peptide Component.
Rincón-Cortés CA; Bayona-Rojas MA; Reyes-Montaño EA; Vega-Castro NA
Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355990
[TBL] [Abstract][Full Text] [Related]
18. Potential Applications of Venom Peptides as Anti-Thrombotic Agents for Management of Arterial and Deep-Vein Thrombosis.
Khan S; Gul A; Noreen R; Ahmed S; Ashraf M; Awan MSB; Niazi ZR; Khan N
Protein Pept Lett; 2018; 25(7):677-687. PubMed ID: 29921198
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.
Perumal Samy R; Pachiappan A; Gopalakrishnakone P; Thwin MM; Hian YE; Chow VT; Bow H; Weng JT
BMC Infect Dis; 2006 Jun; 6():100. PubMed ID: 16784542
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
